Macrophage-mediated chronic lymphocytic leukemia cell survival is independent of APRIL signaling

被引:0
|
作者
MHA van Attekum
S Terpstra
E Reinen
AP Kater
E Eldering
机构
[1] Academic Medical Center,Department of Hematology
[2] University of Amsterdam,Department of Experimental Immunology
[3] Academic Medical Center,undefined
[4] University of Amsterdam,undefined
[5] Lymphoma and Myeloma Center Amsterdam (LYMMCARE),undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Survival of chronic lymphocytic leukemia (CLL) cells is mainly driven by interactions within the lymph node (LN) microenvironment with bystander cells such as T cells or cells from the monocytic lineage. Although the survival effect by T cells is largely governed by the TNFR ligand family member CD40L, the exact mechanism of monocyte-derived cell-induced survival is not known. An important role has been attributed to the TNFR ligand, a proliferation-inducing ligand (APRIL), although the exact mechanism remained unclear. Since we detected that APRIL was expressed by CD68+ cells in CLL LN, we addressed its relevance in various aspects of CLL biology, using a novel APRIL overexpressing co-culture system, recombinant APRIL, and APRIL reporter cells. Unexpectedly, we found, that in these various systems, APRIL had no effect on survival of CLL cells, and activation of NF-κB was not enhanced on APRIL stimulation. Moreover, APRIL stity mulation did not affect CLL proliferation, neither as single stimulus nor in combination with known CLL proliferation stimuli. Furthermore, the survival effect conveyed by macrophages to CLL cells was not affected by transmembrane activator and CAML interactor-Fc, an APRIL decoy receptor. We conclude that the direct role ascribed to APRIL in CLL cell survival might be overestimated due to application of supraphysiological levels of recombinant APRIL.
引用
收藏
相关论文
共 50 条
  • [21] The time to first treatment is an independent predictor of overall survival in chronic lymphocytic leukemia
    Morabito, Fortunato
    Tripepi, Giovanni
    Mauro, Francesca Romana
    Laurenti, Luca
    Reda, Gianluigi
    Moia, Riccardo
    Condoluci, Adalgisa
    Vincelli, Iolanda
    Chiarenza, Annalisa
    Vigna, Ernesto
    Martino, Enrica Antonia
    Bruzzese, Antonella
    Mezzatesta, Sabrina
    Laureana, Roberta
    Cutrona, Giovanna
    Di Raimondo, Francesco
    Fronza, Gilberto
    Zucchetto, Antonella
    Bomben, Riccardo
    Rossi, Francesca Maria
    Olivieri, Jacopo
    Zaja, Francesco
    Rossi, Davide
    Gaidano, Gianluca
    Del Principe, Maria Ilaria
    Ilariucci, Fiorella
    Del Poeta, Giovanni
    Ferrarini, Manlio
    Neri, Antonino
    Gattei, Valter
    Gentile, Massimo
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (07) : E157 - E160
  • [22] POSSIBLE MACROPHAGE-MEDIATED IMMUNE MECHANISM INDEPENDENT OF T-CELL AND B-CELL ACTION
    ROSENTHAL, SR
    RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY, 1978, 21 (02): : 383 - 384
  • [23] Inhibiting efferocytosis reverses macrophage-mediated immunosuppression in the leukemia microenvironment
    Cruz, Joselyn Cruz
    Allison, Kristen C.
    Page, Lauren S.
    Jenkins, Alexis J.
    Wang, Xiaodong
    Earp, H. Shelton
    Frye, Stephen V.
    Graham, Douglas K.
    Verneris, Michael R.
    Lee-Sherick, Alisa B.
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [24] Interleukin 4 Induces Macrophage-Mediated Phagocytosis of Leukemia Cells
    Pena-Martinez, Pablo
    Eriksson, Mia
    Ramakrishnan, Ramprasad
    Chapellier, Marion
    Hogberg, Carl
    Jansson, Caroline
    Nord, David Gisselsson
    Jaras, Marcus
    BLOOD, 2018, 132
  • [25] Predicting survival in chronic lymphocytic leukemia
    Bazargan, Ali
    Tam, Constantine S.
    Keating, Michael J.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (03) : 393 - 403
  • [26] The Role of Phospholipase C Signaling in Macrophage-Mediated Inflammatory Response
    Zhu, Liqian
    Jones, Clinton
    Zhang, Gaiping
    JOURNAL OF IMMUNOLOGY RESEARCH, 2018, 2018
  • [27] A novel role for Hedgehog signaling in macrophage-mediated immune evasion
    Hanna, Ann
    Chen, Dongquan
    Chandrashekar, Darshan S.
    Varambally, Sooryanarayana
    Samant, Rajeev S.
    Shevde, Lalita A.
    CANCER RESEARCH, 2018, 78 (13)
  • [28] The kinase inhibitors R406 and GS-9973 impair T cell functions and macrophage-mediated anti-tumor activity of rituximab in chronic lymphocytic leukemia patients
    Ana Colado
    María Belén Almejún
    Enrique Podaza
    Denise Risnik
    Carmen Stanganelli
    Esteban Enrique Elías
    Patricia Dos Santos
    Irma Slavutsky
    Horacio Fernández Grecco
    María Cabrejo
    Raimundo Fernando Bezares
    Mirta Giordano
    Romina Gamberale
    Mercedes Borge
    Cancer Immunology, Immunotherapy, 2017, 66 : 461 - 473
  • [29] In silico models for B cell receptor signaling in chronic lymphocytic leukemia
    Frushicheva, Maria P.
    Chakraborty, Arup K.
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (01)
  • [30] CENTRAL INHIBITION OF SPLEEN CELL-MEDIATED AND MACROPHAGE-MEDIATED IMMUNITY TO LEUKEMIA L-1210 BY ISOANTIBODY
    MITCHELL, MS
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1971, 12 (NMAR): : 72 - &